KTTA: Pasithea Therapeutics Corp. insider trading, 5% holders and institutional ownership

From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.

Insider trading

0 open-market buys totaling - and 0 sales totaling - in the last 180 days.

Activist and 5% holders

FiledWhatHolderStakeChangeFiling
2026-08-1413G amendmentVivo Opportunity Fund Holdings, L.P.9.99%SEC
2026-07-3113G amendmentOpaleye Management Inc.6.14%SEC

Institutional ownership (Q2 2026)

25 institutions reported holding $8.66M of Pasithea Therapeutics Corp. on Form 13F (21 the quarter before). 4 opened a new position and 0 sold out. Shares held by institutions: +31%.

Largest holdersSharesValue
Cable Car Capital, LP3,000,000$1.55M
Stonepine Capital Management, LLC2,201,468$1.13M
Jupiter Topco LLC2,100,000$1.09M
ADAGE CAPITAL PARTNERS GP, L.L.C.2,100,000$1.08M
Opaleye Management Inc.2,050,000$1.06M
AMERIPRISE FINANCIAL INC1,864,485$961K
Squadron Capital Management LLC1,000,000$515K
AdvisorShares Investments LLC937,550$483K
Vivo Capital, LLC465,471$240K
Persistent Asset Partners Ltd290,555$150K

Get new insider and activist filings the morning after: daily alerts. Not investment advice.